ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Octapharma at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Octapharma brings 1 presentation to ACR Convergence 2026 in Orlando, and exhibits at Booth 2938. Its program covers immunoglobulin therapy, looking at immune modulation and infection prevention.

OrganizationACR Convergence 2026 Attendance
Pharmaceutical companies
Global manufacturer of plasma-derived and recombinant therapies.
Booth
Exhibiting at Booth 2938
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Tue Nov 10
12:30pm–1:15pm
Immunoglobulin Therapy: Immune Modulation and Infection Prevention
Innovation Theater A
Treatment safety · Infection · with Emory University, Johns Hopkins University

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Octapharma

Tell us what you sell and we’ll find the people at Octapharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction